(CercleFinance.com) – UBS reduced its target price on Eiffage on Monday from 136 to 134 euros, a level which still represents an upside potential of 55% compared to the current stock market price.
In a note released in the morning, the analyst maintains his buy recommendation on the action, praising both its defensive status and its so-called ‘value’ qualities, i.e. a quality discounted security.
“We believe that the market significantly undervalues the composition of the assets that Eiffage currently controls, which we believe are valued conservatively,” continues the intermediary, referring in particular to APRR’s stake in Atlas. Arteria.
From UBS’s point of view, the title remains ‘very cheap for such a defensive earnings profile’.
Copyright © 2022 CercleFinance.com. All rights reserved.
The information and analyzes disseminated by Cercle Finance only constitute a decision-making aid for investors. The responsibility of Cercle Finance cannot be held directly or indirectly following the use of information and analyzes by readers. It is recommended that any uninformed person consult a professional adviser before any investment. This indicative information does not in any way constitute an incitement to sell or a solicitation to buy.
Did you like this article ? Share it with your friends with the buttons below.
